Current Pharmaceutical Design

William A. Banks  
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA

Back

From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights

Author(s): Samuele De Minicis, Chris Day, Gianluca Svegliati-Baroni.

Abstract:

NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.

Keywords: NAFLD, NASH, fibrosis, microbiota, bacterial translocation.

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 19
ISSUE: 29
Page: [5239 - 5249]
Pages: 11
DOI: 10.2174/1381612811319290006
Price: $58